News for BioMimetic Therapeutics, Inc. - Google Finance

Wright Medical Group, Inc. Appoints Douglas G. Watson to Board of Directors

Tue, 14 May 2013 20:00:44 GMT

Wright Medical Group, Inc. Appoints Douglas G. Watson to Board of Directors
MarketWatch (press release) - May 14, 2013

Prior board memberships have included BioMimetic Therapeutics, Inc., Genta Incorporated, Javelin Pharmaceuticals, Inc., Engelhard Corporation and Summit Bank Corporation, all public companies, and Bionor Immuno AS and BZL Biologics Inc., both ...

Wright Medical Stays Neutral - Analyst Blog

Wed, 22 May 2013 18:28:30 GMT

Wright Medical Stays Neutral - Analyst Blog
NASDAQ - May 22, 2013

The combination with BioMimetic Therapeutics will improve competitive advantage. However, dilution is expected to ... Rank #2 (Buy) and are expected to do well. In addition, Conceptus, Inc. ( CPTS ) carries a Zacks Rank #1 (Strong Buy) and warrants a look.

Locust Walk Partners Appoints MD

Wed, 15 May 2013 08:45:10 GMT

Locust Walk Partners Appoints MD
Thomson Reuters' peHUB (press release) - May 15, 2013

Prior to Locust Walk, Mr. Ehrlich was a Managing Director at InterWest Partners, during which time he served on the boards of KAI Pharmaceuticals (acquired by Amgen) and Biomimetic Therapeutics, Inc. (acquired by Wright Medical Technologies).

Wright Medical Group, Inc. Reports 2013 First Quarter Financial Results

Wed, 01 May 2013 10:26:34 GMT

Wright Medical Group, Inc. Reports 2013 First Quarter Financial Results
Business Wire (press release) - May 1, 2013

By way of example and without implied limitation, such risks and uncertainties include: failure to realize the anticipated financial and other benefits from the acquisition of BioMimetic Therapeutics, Inc. or a delay in realization thereof; failure to ...

MISONIX, INC. : Misonix Appoints Scott Ludecker Vice President of Global Sales ...

Mon, 13 May 2013 17:10:31 GMT

MISONIX, INC. : Misonix Appoints Scott Ludecker Vice President of Global Sales ...
4-traders (press release) - May 13, 2013

Mr. Ludecker most recently served as Vice President of Global Sales and Marketing for BioMimetic Therapeutics, a NASDAQ-listed biotechnology company, specializing in the development and commercialization of products which promote the healing of ...

Misonix Appoints Scott Ludecker Vice President of Global Sales and Marketing - The Herald | HeraldOnline.com

Wright Medical Group Inc Completes Acquisition Of BioMimetic Therapeutics, Inc.

Fri, 01 Mar 2013 10:59:00 GMT

Wright Medical Group Inc Completes Acquisition Of BioMimetic Therapeutics, Inc.
Reuters Key Development - Mar 1, 2013

Law Office of Brodsky & Smith, LLC Announces Investigation of BioMimetic Therapeutics Inc

Tue, 20 Nov 2012 19:57:00 GMT

Law Office of Brodsky & Smith, LLC Announces Investigation of BioMimetic Therapeutics Inc
Reuters Key Development - Nov 20, 2012

Faruqi & Faruqi, LLP Announces Investigation Of Board Of Directors Of BioMimetic Therapeutics Inc

Tue, 20 Nov 2012 00:01:00 GMT

Faruqi & Faruqi, LLP Announces Investigation Of Board Of Directors Of BioMimetic Therapeutics Inc
Reuters Key Development - Nov 20, 2012

Rigrodsky & Long, P.A. Announces Investigation Of BioMimetic Therapeutics Inc. Buyout

Mon, 19 Nov 2012 17:23:00 GMT

Rigrodsky & Long, P.A. Announces Investigation Of BioMimetic Therapeutics Inc. Buyout
Reuters Key Development - Nov 19, 2012

Wright Medical Group Inc and BioMimetic Therapeutics Inc Enter Into Agreement to Combine Businesses

Mon, 19 Nov 2012 11:30:00 GMT

Wright Medical Group Inc and BioMimetic Therapeutics Inc Enter Into Agreement to Combine Businesses
Reuters Key Development - Nov 19, 2012